320 related articles for article (PubMed ID: 22564577)
1. Endomyocardial biopsy in heart transplantation: schedule or event?
Chi NH; Chou NK; Tsao CI; Huang SC; Wu IH; Yu HY; Chen YS; Wang SS
Transplant Proc; 2012 May; 44(4):894-6. PubMed ID: 22564577
[TBL] [Abstract][Full Text] [Related]
2. Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation.
White JA; Guiraudon C; Pflugfelder PW; Kostuk WJ
J Heart Lung Transplant; 1995; 14(6 Pt 1):1052-6. PubMed ID: 8719450
[TBL] [Abstract][Full Text] [Related]
3. Antithymocyte globulin induction therapy adjusted for immunologic risk after heart transplantation.
Czer LS; Phan A; Ruzza A; Rafiei M; Setareh-Shenas S; Caceres M; Awad M; Soliman C; Mirocha J; De Robertis M; Kass RM; Trento A
Transplant Proc; 2013; 45(6):2393-8. PubMed ID: 23953554
[TBL] [Abstract][Full Text] [Related]
4. Gene-expression profiling for rejection surveillance after cardiac transplantation.
Pham MX; Teuteberg JJ; Kfoury AG; Starling RC; Deng MC; Cappola TP; Kao A; Anderson AS; Cotts WG; Ewald GA; Baran DA; Bogaev RC; Elashoff B; Baron H; Yee J; Valantine HA;
N Engl J Med; 2010 May; 362(20):1890-900. PubMed ID: 20413602
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of routine surveillance endomyocardial biopsy 6 months after heart transplantation.
Orrego CM; Cordero-Reyes AM; Estep JD; Loebe M; Torre-Amione G
J Heart Lung Transplant; 2012 Aug; 31(8):845-9. PubMed ID: 22609184
[TBL] [Abstract][Full Text] [Related]
6. Results with expanded donor acceptance criteria in heart transplantation.
Forni A; Luciani GB; Chiominto B; Pizzuti M; Mazzucco A; Faggian G
Transplant Proc; 2011 May; 43(4):953-9. PubMed ID: 21620025
[TBL] [Abstract][Full Text] [Related]
7. Randomized pilot trial of gene expression profiling versus heart biopsy in the first year after heart transplant: early invasive monitoring attenuation through gene expression trial.
Kobashigawa J; Patel J; Azarbal B; Kittleson M; Chang D; Czer L; Daun T; Luu M; Trento A; Cheng R; Esmailian F
Circ Heart Fail; 2015 May; 8(3):557-64. PubMed ID: 25697852
[TBL] [Abstract][Full Text] [Related]
8. Utility of surveillance biopsies in infant heart transplant recipients.
Balzer DT; Moorhead S; Saffitz JE; Huddleston CB; Spray TL; Canter CE
J Heart Lung Transplant; 1995; 14(6 Pt 1):1095-101. PubMed ID: 8719456
[TBL] [Abstract][Full Text] [Related]
9. Survival and allograft rejection rates after combined heart and kidney transplantation in comparison with heart transplantation alone.
Czer LS; Ruzza A; Vespignani R; Jordan S; De Robertis MA; Mirocha J; Gallagher SP; Patel K; Schwarz ER; Kass RM; Trento A
Transplant Proc; 2011 Dec; 43(10):3869-76. PubMed ID: 22172862
[TBL] [Abstract][Full Text] [Related]
10. Cardiac transplantation in the United States: an analysis of the UNOS registry.
Everly MJ
Clin Transpl; 2008; ():35-43. PubMed ID: 19708444
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of patients with Banff borderline changes in renal allograft biopsies.
El-Agroudy AE; Wafa EW; Abbas TM; El-Husseini A; Gheith OA; El-Baz M; Ghoneim MA
Exp Clin Transplant; 2009 Dec; 7(4):228-32. PubMed ID: 20353372
[TBL] [Abstract][Full Text] [Related]
12. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.
Stojanovic I; Vrtovec B; Radovancevic B; Radovancevic R; Yazdanbakhsh AP; Thomas CD; Frazier OH
J Heart Lung Transplant; 2005 Sep; 24(9):1235-8. PubMed ID: 16143239
[TBL] [Abstract][Full Text] [Related]
13. Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant.
Everitt MD; Hammond ME; Snow GL; Stehlik J; Revelo MP; Miller DV; Kaza AK; Budge D; Alharethi R; Molina KM; Kfoury AG
J Heart Lung Transplant; 2012 Jul; 31(7):686-93. PubMed ID: 22551931
[TBL] [Abstract][Full Text] [Related]
14. A single-center retrospective clinicopathologic study of endomyocardial biopsies after heart transplant at Baskent University Hospital in Ankara, 1993-2014.
Terzi A; Sezgin A; Tunca Z; Deniz E; Ayva EŞ; Haberal Reyhan N; Müderrisoğlu H; Özdemir BH
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():346-51. PubMed ID: 25894188
[TBL] [Abstract][Full Text] [Related]
15. Timing of the first endomyocardial biopsy in heart transplantation after induction immunosuppressive therapy--experience from Canadian Heart Transplant Centre.
Málek F; Kaan A; Straatman L; Cheung A; Gnaszewski A
Cas Lek Cesk; 2005; 144(8):507-9; discussion 509. PubMed ID: 16173602
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
[TBL] [Abstract][Full Text] [Related]
17. Routine surveillance endomyocardial biopsy: late rejection after heart transplantation.
Heimansohn DA; Robison RJ; Paris JM; Matheny RG; Bogdon J; Shaar CJ
Ann Thorac Surg; 1997 Nov; 64(5):1231-6. PubMed ID: 9386684
[TBL] [Abstract][Full Text] [Related]
18. Unsuspected rejection episodes on routine surveillance endomyocardial biopsy post-heart transplant in paediatric patients.
Dixon V; Macauley C; Burch M; Sebire NJ
Pediatr Transplant; 2007 May; 11(3):286-90. PubMed ID: 17430484
[TBL] [Abstract][Full Text] [Related]
19. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
20. Creatine kinase MB isoforms: a potential predictor of acute cardiac allograft rejection.
Anderson JR; Hossein-Nia M; Brown PA; Corbishley C; Murday AJ; Holt DW
J Heart Lung Transplant; 1995; 14(4):666-70. PubMed ID: 7578173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
